Spanish Registry of Patients With Sleep Apnea and Daytime Sleepiness
NCT ID: NCT06514482
Last Updated: 2025-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2022-10-28
2025-10-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
OSA patients will be evaluated at baseline, 6, 12, and 24 months.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Cost-Effectiveness and Sensitivity of Automatic Analysis Versus Manual Analysis of Polygraphy in the Diagnosis of Obstructive Sleep Apnea.
NCT06458777
Global Self-management Telematic Support for Patients With Obstructive Sleep Apnea.
NCT03792880
Multidimensional System as Predictor of Outcomes in Obstructive Sleep Apnea: The OSA-SCORE
NCT01175421
Enhancing PAP Adherence Among Spanish-speaking Hispanic Adults With OSA
NCT05618444
Diagnosis of Patients With Low or Intermediate Suspicion of SAHS or With Comorbidity: Standard Laboratory Polysomnography Compared With Three Nights of Home Respiratory Polygraphy.
NCT01820156
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NO OSA
Control group
Diagnosis
Diagnosis
OSA WHITH CPAP
Diagnosis
Diagnosis
OSA WHITHOUT CPAP
Diagnosis
Diagnosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnosis
Diagnosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients older than 18 years.
* Signature of the informed consent.
Exclusion Criteria
* Presence of any previously diagnosed sleep disorder: narcolepsy, insomnia, sleep deprivation (less than 6h/day), regular use of medications hypnotics or sedatives (may be included if you only use a short-acting benzodiazepine or melatonin) and restless legs syndrome.
* Patients with \> 50% central apnea or presence of Cheyne-Stokes respiration (CSRsp).
* A medical history that may interfere with the objectives of the study or that in the judgment of the investigator compromises the conclusions.
* Any medical, social or geographical factor that may endanger the patient compliance. (eg, alcohol consumption (more than 80 g/day in men and more than 60 gr / day in women), absence of stable habitual residence, disorientation or non-compliance history).
* Any process, cardiovascular or not, that limits life expectancy to less than one year.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital San Pedro de Logroño
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital San Pedro
Logroño, La Rioja, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI 569
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.